Amphastar Pharmaceuticals, Inc. — Director's Dealing 2016

Jun 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2016-06-15

Reporting Person: Gerst Diane G. (EVP, QA & Regulatory Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-15	Common Stock	F	146	$15.76	Disposed	28985	Direct

Footnotes

F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of deferred stock units, or DSUs.

F2: Includes 482 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan.